NCI News Releases
02 March 2021
The latest cancer news from the U.S. government's principal agency for cancer research.-
NCI study finds that people with SARS-CoV-2 antibodies may have a low risk of future infection
A prior infection with SARS-CoV-2, the virus that causes COVID-19, appears to protect, at least for a few months, against reinfection from the virus, according to an NCI study. The finding may have important public health implications.
-
Fecal microbiota transplants help patients with advanced melanoma respond to immunotherapy
For patients with cancers that do not respond to immunotherapy drugs, the use of fecal transplants to modify the gut microbiome may help some of these patients respond to the immunotherapy drugs.
-
Some postmenopausal women with breast cancer may forgo chemotherapy
Some postmenopausal women with HR-positive, HER2-negative breast cancer may not benefit from chemotherapy and can safely forgo the treatment, according to clinical trial results presented at the San Antonio Breast Cancer Symposium.
NCI Fact Sheets
02 March 2021
The latest NCI fact sheets on a wide array of cancer topics including risk factors, prevention, support, treatment, and more.-
Tumor Markers
A fact sheet that defines tumor markers and describes how they can be used to aid diagnosis and treatment.
-
Targeted Cancer Therapies
A fact sheet that describes targeted cancer therapies, which are drugs that interfere with specific molecules involved in cancer cell growth and survival.
-
Genetic Testing for Inherited Cancer Susceptibility Syndromes
A fact sheet about genetic testing for inherited cancer risk, including who should consider testing, how to understand test results, and who has access to a person’s test results. Also contains information about at-home, or direct-to-consumer, genetic tests.
